Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
-0.63%
)
US TECH 100
25,946.80
(
0.67%
)
Dow Jones
49,149.38
(
-0.60%
)
Brent Oil
95.30
(
0.31%
)
Bitcoin
78,039.79
(
2.24%
)
News Focus
News Focus
Post# of 257433
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122881
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: anesthesia doc post# 189190

Thursday, 03/26/2015 9:18:07 AM

Thursday, March 26, 2015 9:18:07 AM

Post# of 257433
CNAT +46% PM on biomarker results in NAFLD/NASH. The biomarker data are as good as can be expected, but they are not actual signs of efficacy.

There will be three other phase-2 Emricasan trials reading out in 2015 in various indications.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today